Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization

doi:10.4254/wjh.v7.i12.1694

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8318)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

492

WORD

354

HTML

4065

Figures (1-3)

210

Tables (1-1)

194

Sum=5315

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1105

Download

1898

Sum=3003

Jun 28, 2015 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Jun 28, 2015; 7(12): 1694-1700
Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1694

Table 1 Demographics and clinical characteristics of the series

Characteristics
Gender (male), n	5
Mean age (yr) ± SD	59 ± 6
Mean aspartate aminotransferase levels (IU/L) ± SD	68.8 ± 53
Mean alanine transaminase levels (IU/L) ± SD	62.5 ± 65
Mean gamma-glutamyl-transpeptidase levels (IU/L) ± SD	156 ± 211
Mean creatinine levels (mg/dL)	0.86 ± 0.25
Mean international normalized ratio	1.2 ± 0.1
Mean platelet levels (10³/μL) ± SD	975000 ± 57000
Mean alfa fetoprotein (ng/mL) ± SD	14.9 ± 21.4

Citation: Orlacchio A, Chegai F, Merolla S, Francioso S, Giudice CD, Angelico M, Tisone G, Simonetti G. Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization. World J Hepatol 2015; 7(12): 1694-1700
URL: https://www.wjgnet.com/1948-5182/full/v7/i12/1694.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i12.1694